Sunesis Pharmaceuticals Inc (SNSS):企業の財務・戦略的SWOT分析

◆英語タイトル:Sunesis Pharmaceuticals Inc (SNSS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15774
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sunesis Pharmaceuticals Inc (SNSS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sunesis Pharmaceuticals Inc (Sunesis), formerly Mosaic Pharmaceuticals, Inc. develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company’s Vosaroxin is being developed in Phase III clinical trials for the treatment of acute myeloid leukemia (AML). It is a first-in-class anti-cancer quinolone derivative that has not been used previously for the treatment of cancer. The drug candidate is also being evaluated in Phase III clinical trials for the treatment of myelodysplastic syndromes (MDS). Its other products under pipeline include TAK-580 and SNS-510 for solid tumors, and Vecabrutinib (SNS-062) for B-cell malignancies. The company collaborates with pharmaceutical companies such as Biogen, Millennium Pharmaceuticals, Inc. and Sumitomo Dainippon to obtain licenses to develop certain products. Sunesis is headquartered in South San Francisco, California, the US.

Sunesis Pharmaceuticals Inc Key Recent Developments

Mar 07,2019 Sunesis Pharmaceuticals reports fourth quarter and full-year 2018 financial results and recent highlights
Jan 02,2019 Sunesis Pharmaceuticals Announces Advancement into 100mg Cohort of Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies
Nov 05,2018 Sunesis Pharmaceuticals reports third quarter 2018 financial results and recent highlights
Aug 07,2018 Sunesis Pharmaceuticals reports second quarter 2018 financial results and recent highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sunesis Pharmaceuticals Inc – Key Facts
Sunesis Pharmaceuticals Inc – Key Employees
Sunesis Pharmaceuticals Inc – Key Employee Biographies
Sunesis Pharmaceuticals Inc – Major Products and Services
Sunesis Pharmaceuticals Inc – History
Sunesis Pharmaceuticals Inc – Company Statement
Sunesis Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sunesis Pharmaceuticals Inc – Business Description
Sunesis Pharmaceuticals Inc – Corporate Strategy
Sunesis Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Sunesis Pharmaceuticals Inc – Strengths
Sunesis Pharmaceuticals Inc – Weaknesses
Sunesis Pharmaceuticals Inc – Opportunities
Sunesis Pharmaceuticals Inc – Threats
Sunesis Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Sunesis Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 07, 2019: Sunesis Pharmaceuticals reports fourth quarter and full-year 2018 financial results and recent highlights
Jan 02, 2019: Sunesis Pharmaceuticals Announces Advancement into 100mg Cohort of Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies
Nov 05, 2018: Sunesis Pharmaceuticals reports third quarter 2018 financial results and recent highlights
Aug 07, 2018: Sunesis Pharmaceuticals reports second quarter 2018 financial results and recent highlights
Jul 09, 2018: Sunesis Pharmaceuticals Announces Senior Management Changes
May 08, 2018: Sunesis Pharmaceuticals Announces First Quarter 2018 Financial Results
Mar 08, 2018: Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Highlights
Feb 07, 2018: Sunesis Pharmaceuticals Appoints Industry Veteran H. Ward Wolff to the Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sunesis Pharmaceuticals Inc, Key Facts
Sunesis Pharmaceuticals Inc, Key Employees
Sunesis Pharmaceuticals Inc, Key Employee Biographies
Sunesis Pharmaceuticals Inc, Major Products and Services
Sunesis Pharmaceuticals Inc, History
Sunesis Pharmaceuticals Inc, Subsidiaries
Sunesis Pharmaceuticals Inc, Key Competitors
Sunesis Pharmaceuticals Inc, Ratios based on current share price
Sunesis Pharmaceuticals Inc, Annual Ratios
Sunesis Pharmaceuticals Inc, Annual Ratios (Cont...1)
Sunesis Pharmaceuticals Inc, Interim Ratios
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Sunesis Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sunesis Pharmaceuticals Inc, Performance Chart (2014 - 2018)
Sunesis Pharmaceuticals Inc, Ratio Charts
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Sunesis Pharmaceuticals Inc (SNSS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Romelectro S.A.:企業の戦略的SWOT分析
    Romelectro S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Young & Co.’s Brewery plc (YNGA):企業の財務・戦略的SWOT分析
    Young & Co.'s Brewery plc (YNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Lycera Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Lycera Corp (Lycera) is a biopharmaceutical company that focuses on the development of oral immune modulators for the treatment of patients with autoimmune diseases and cancer. The company’s pipeline products include LYC-55716, an oral retinoic acid-related orphan receptor gamma (RORgamma) a …
  • Allan Myers Inc:企業の戦略・SWOT・財務分析
    Allan Myers Inc - Strategy, SWOT and Corporate Finance Report Summary Allan Myers Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Village Roadshow Ltd:企業の戦略・SWOT・財務情報
    Village Roadshow Ltd - Strategy, SWOT and Corporate Finance Report Summary Village Roadshow Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • NuStar Energy L.P.:企業の戦略・SWOT・財務分析
    NuStar Energy L.P. - Strategy, SWOT and Corporate Finance Report Summary NuStar Energy L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hyundai Corporation:企業の戦略・SWOT・財務分析
    Hyundai Corporation - Strategy, SWOT and Corporate Finance Report Summary Hyundai Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • GNI Group Ltd (2160):企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery and …
  • The Buckle, Inc.:企業の戦略・SWOT・財務情報
    The Buckle, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Buckle, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Finox AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Finox AG (Finox), a subsidiary of Richter Gedeon Nyrt, is a drug development and manufacturing company that offers fertility treatment products. The company develops drugs in the field of fertility therapies. Its product portfolio includes biosimilars and patient friendly delivery devices. F …
  • One Medical Group Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary One Medical Group Inc (One Medical) is a provider of medical and technology-enabled health care services. The company’s service offerings include primary and pediatric care, prenatal and women's health, nutrition and sports medicine, LGBT care, mental health, dermatology, family and integrat …
  • Wakefern Food Corp.:企業の戦略的SWOT分析
    Wakefern Food Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Furukawa Electric Co Ltd (FUWAY):企業の財務・戦略的SWOT分析
    Furukawa Electric Co Ltd (FUWAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Northwestern University:企業のM&A・事業提携・投資動向
    Northwestern University - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Northwestern University Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Ortivus AB (ORTI B):企業の財務・戦略的SWOT分析
    Summary Ortivus AB (Ortivus) is a supplier of mobile solutions for emergency medical care. The company develops and offers cardiology, and mobile monitoring and communication solutions. Its products include MobiMed Smart, CoroNet, excense heart record system and excense decision support healthcare s …
  • Travelsky Technology Ltd (696):企業の財務・戦略的SWOT分析
    Travelsky Technology Ltd (696) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • EGYPTAIR Holding Company:企業の戦略・SWOT・財務情報
    EGYPTAIR Holding Company - Strategy, SWOT and Corporate Finance Report Summary EGYPTAIR Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Teradyne, Inc.:企業の戦略・SWOT・財務情報
    Teradyne, Inc. - Strategy, SWOT and Corporate Finance Report Summary Teradyne, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Banca Sella Holding SpA:企業の戦略的SWOT分析
    Banca Sella Holding SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Nagacorp Ltd:戦略・SWOT・企業財務分析
    Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report Summary Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆